1. Introduction Click to copy section linkSection link copied! As of November 29, 2023, 80 kinase-targeted small molecule drugs have been approved by the United States Food and Drug Administration (FDA), illustrating the value of kinase drug development for the treatment of a variety of diseases, (1−3) such as nonsmall cell lung cancer.
Philip E. Bourne
As seen in:
UVA Data Points,
slideshare.net,
Nature,
Wiley Online Library,
PLOS,
PLOS Biology,
ACS Publications,
Science Magazine,
BioRxiv,
Richmond Times-Dispatch,
PeerJ
and
Dean, School of Data Science, Professor, Dept. of Biomedical Engineering, The University of Virginia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Philip E.
Contact Philip E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack